Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
13F holders, Q4 2025
Institutional positions in Alterity Therapeutics Ltd as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q3 2025
- Shares held
- 325.1K
- −9.54K (−2.9%) vs. Q3 2025
- Total value
- $1.00M
- −$258.2K (−20.5%) vs. Q3 2025
- New holders
- 4
- 1 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATHE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.12M |
| Q1 2026 | 15 | $1.12M |
| Q4 2025 | 18 | $1.00M |
| Q3 2025 | 16 | $1.26M |
| Q2 2025 | 11 | $906.9K |
| Q1 2025 | 12 | $833.9K |
| Q4 2024 | 13 | $415.9K |
| Q3 2024 | 13 | $148.6K |
| Q2 2024 | 10 | $140.9K |
| Q1 2024 | 10 | $193.8K |
| Q4 2023 | 9 | $226.7K |
| Q3 2023 | 8 | $143.5K |
| Q2 2023 | 7 | $163.2K |
| Q1 2023 | 7 | $260.3K |
| Q4 2022 | 13 | $230.5K |
| Q3 2022 | 9 | $299.0K |
| Q2 2022 | 10 | $441.0K |
| Q1 2022 | 13 | $643.0K |
| Q4 2021 | 11 | $541.0K |
| Q3 2021 | 14 | $808.1K |
| Q2 2021 | 14 | $1.29M |
| Q1 2021 | 12 | $1.45M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Alterity Therapeutics Ltd; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Twin Lakes Capital Management, LLC | 139,258 | $428.9K | 0.19% | 00.0% | Unchanged |
| Morgan Stanley | 63,682 | $196.1K | 0.00% | −5,000−7.3% | Reduced |
| HB Wealth Management, LLC | 58,460 | $180.1K | 0.00% | 00.0% | Unchanged |
| Greenleaf Trust | 32,000 | $98.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,811 | $51.8K | 0.00% | −5,333−24.1% | Reduced |
| BNP Paribas Arbitrage, SA | 6,909 | $21.3K | 0.00% | −400−5.5% | Reduced |
| Acadian Asset Management LLC | 4,799 | $14.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,127 | $6.55K | 0.00% | +1,241+140.1% | Added |
| GAMMA Investing LLC | 790 | $2.43K | 0.00% | +790 | New |
| Advisor Group Holdings, Inc. | 81 | $247 | 0.00% | −100−55.2% | Reduced |
| Ronald Blue Trust, Inc. | 40 | $123 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 22 | $68 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 21 | $65 | 0.00% | +21 | New |
| Tower Research Capital LLC (TRC) | 10 | $31 | 0.00% | +10 | New |
| Steward Partners Investment Advisory, LLC | 6 | $18 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $3 | 0.00% | −635−99.8% | Reduced |
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Motiv8 Investments LLC | 40 | $0 | 0.00% | +40 | New |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |